Exerti onal rhabdomyolysis results from muscle tissue breakdown, which presents a significant concern for the possibility of renal failure. [1] [2] [3] [4] [5] Athletic trainers and therapists (ATs) need to be knowledgeable about its prevention and treatment, as well as considerations for safe return to activity. Rhabdomyolysis is diagnosed on the basis of elevation of serum creatine kinase (CK) and myoglobin (Mb). [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The same biological markers can be used to assess readiness for return to activity, but much of the available literature on the topic has focused on serum CK level as the basis for the decision. 1, [11] [12] [13] [16] [17] [18] [19] [20] There is research evidence, however, that serum Mb may be a more sensitive indicator of physiologic status. [6] [7] [8] [9] [10] 14, 15 The purpose of this report is to review the evidence for use of Mb as a more sensitive marker for making a return-to-play decision after exertional rhabdomyolysis has been diagnosed.
Pathogenesis
Exertional rhabdomyolysis results from insufficient synthesis of adenosine triphosphate (ATP) to meet energy demands, which is typically associated with excessive muscular activity, temperature extremes, and muscle ischemia. 6 Cell destruction caused by rhabdomyolysis occurs much faster in extreme heat, 6 which has been associated with muscle in military personnel, football players, and individuals participating in intense physical activity ( Figure 1 ). 1, 2, 17, 19, [21] [22] [23] [24] Rhabdomyolysis involves disruption of the sarcolemma and intracellular structural components. [3] [4] [5] 16 Hypoxia, ATP depletion, and alteration of sodium-potassium electrolyte balance may contribute to increased serum CK and Mb levels. [3] [4] [5] 16 Excessive serum CK and Mb levels can lead to kidney failure and death when untreated, [3] [4] [5] 16 but a catastrophic outcome is unlikely. 25 Some physicians may use CK as the only biological marker for the diagnosis of exertional rhabdomyolysis and for subsequent assessment of readiness for return to play. 1, [11] [12] [13] [16] [17] [18] [19] [20] There is a body of evidence, however, that supports the use of Mb as a biological marker for evaluation of physiologic status. 6-10
Biochemical Markers
Serum CK levels vary between physically fit athletes and sedentary individuals. The range of normative values observed in the general population may not include levels measured in highly trained athletes who are in a constant state of muscle rebuilding. 6,7 Because athletes can have resting serum CK levels that are substantially greater than those for untrained individuals, 25 physician use of normative values derived from the general population may adversely affect diagnostic accuracy and probably should not be used for assessment of readiness to return to play (Table 1) . 13, 26, 27 Untrained individuals will also exhibit greater increase in serum CK levels than athletes during fatiguing activity. 12, 28, 29 The presence of an appreciable quantity of Mb in the serum is abnormal for anyone (abnormal values range from 4.5 to 37.5ug/ml). 10 Research has demonstrated that CK level does not accurately predict renal failure, but a serum Mb level above 1000 ng/ml does appear to relate to renal failure. 9,30 Dark cola-colored urine, commonly associated with rhabdomyolysis, does not occur unless urine myoglobin levels exceed 100 mg/dL. 16 A possible reason for variability in CK level is transport of the large CK molecule through the lymphatic system, which delays serum CK peak until 96 to 120 hours postexercise or postinjury. 7 Mb is a much smaller molecule that is readily transported within the vascular system, which allows for a more rapid serum Mb peak at 24 to 72 hours postexercise or postinjury. 7 Variability in CK levels are also influenced by gender, ethnicity, and environmental temperature. CK levels tend to be higher in individuals who participate in cold weather activities. 12, 28, 29 Females typically have lower CK levels than males do, 11 which is an important factor to consider when reviewing published case studies. The literature contains 15 case studies on exertional rhabdomyolysis in male athletes and military personnel, but none report cases involving female patients. 1, 2, 17, 19, [21] [22] [23] [24] CK levels could be assessed as part of a preparticipation physical examination, but the cost of testing may be prohibitive. 11 Lacking baseline serum CK data, and considering the variability in serum CK levels, serum Mb level may provide a better indicator of readiness to return to play. 14 
Return to Activity
A clearly-defined standard for return to play following a diagnosis of exertional rhabdomyolysis is not available in the literature. Return to activity ranges from none (i.e., mortality) to one month following symptom onset (Table 2) . One case study has recommended a 15-week return to play progression, but the case reported involved a return to play within seven days. 23 No timeline for follow-up evaluation of biological markers related to exertional rhabdo myolysis has been established. 23 Therefore, the following guidelines are recommended for the return to play of athletes who have been diagnosed with exertional rhabdomyolysis.
1. Return to activity should be individualized. Because rhabdomyolysis often occurs in individuals who have other concomitant conditions, 1, 2, 17, 19, [21] [22] [23] [24] numerous variables may play a role in determination of an appropriate timeline for return to activ- Presentation 4 hr post infarction Decline 6 -8 hours Half Life: 2 -3 hours *Normal ranges are as much dictated by historical texts and medical literature as they are by manufacturers and laboratories. We have provided norms from current and reputable research; however, clinicians should regard the information provided by the overseeing physician and laboratory as well as the information provided in this text.
